Forterra plc Director/PDMR Shareholding

RNS Number : 4752K

Forterra plc

12 April 2024

 

12 April 2024

Forterra plc (the "Company")

Director / PDMR Shareholdings

Further to the maturity of the Forterra 2020 Save As You Earn Scheme (SAYE) on 1 December 2023, on 9 April 2024 the Company was notified by the scheme's administrators, Link Group, of the following PDMR transaction. The PDMR listed below exercised options over the share capital of the Company as follows:

Name	Role	Status	No. of options exercised	Exercise Price	Beneficial interest	% of ISC
George Steward	Director	PDMR	12,080	£1.49	81,541	< 1%

The exercise price of £1.49 was set upon the launch of the scheme in 2020 in line with HMRC rules. 

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

Enquiries

Forterra plc:	[phone]
Frances Tock (Company Secretary)
FTI Consulting:	[phone]
Richard Mountain/Nick Hasell

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	George Stewart
2.	Reason for the notification
a)	Position/status	PDMR (Strategy and Development Director)
b)	Initial notification/Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Forterra plc
b)	LEI	5299007SD2PDQMKM5278
4.	Details of the transaction(s):
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 1p each   GB00BYYW3C20
b)	Nature of the transaction	Exercise of share options with an exercise price of £1.35p under the Forterra SAYE scheme
c)	Price(s) and volume(s)	Transaction Price(s) Volume(s)  Purchase £1.49     12,080 options maturing
d)	Aggregated information	Transaction Price(s) Volume(s) Total  Purchase £1.49 12,080 £17,999.20

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHGPURUCUPCGGP